Study Sheds Light On TAVR Deterioration, Authors Propose New Studies
This article was originally published in Clinica
Executive Summary
Large echocardiographic studies of transcatheter aortic valve (TAVR) patients must be conducted to understand the risk of valve hemodynamic deterioration in these patients and identify what, if any, antithrombotic drug regimen could reduce this risk, according to the investigators of a large multicenter registry study.